Skip to main content

Covestor Ltd

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1909846 LONDON, X0

Position in BBIO

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$102,181
-$18,214 QoQ
Shares Held
1,376
-12.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 7.4854651162790695.ToString("F0")% Shared 0.ToString("F0")% None 92.51453488372093.ToString("F0")%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Derivatives in BBIO

reported options exposure · as of Sep 30, 2024
CallValue
$0
CallShares
0
PutValue
$712
PutShares
28

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Covestor Ltd holds $3,313,348 across 163 Biotechnology names. BBIO ranks #7 (3.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 BBIO
BridgeBio Pharma, Inc.
This page
1,376 $102,181

All Filings in BBIO

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $102,181 1,376
2025-12-31 $120,395 1,574
2025-09-30 $84,610 1,629
2025-06-30 $208,775 4,835
2025-03-31 $408,340 11,812
2024-12-31 $575,361 20,968
2024-09-30 $712 28
2024-09-30 $580,666 22,807
2024-06-30 $303 12
2024-06-30 $313,458 12,375
2024-03-31 $267,674 8,657
2023-12-31 $292,722 7,251
2023-09-30 $252,809 9,587
2023-06-30 $71,225 4,141
2023-03-31 $298 18
2022-12-31 $137 18
2022-09-30 $188 19
2022-06-30 $199 22
2022-03-31 $294 29
2021-12-31 $1,951 117